CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 46, 2011, Pages 18778-18783

  Chen, Liwen ^a   Zhu, Yibei ^a   Zhang, Guangbo ^a,b   Gao, Chao ^a   Zhong, Weixue ^a   Zhang, Xueguang ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cytokine; Fusion protein; Immune regulation; Transcription factor

Indexed keywords

CD38 ANTIGEN; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, CD; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULINS; INTERFERON-GAMMA; INTERLEUKIN-2; MEMBRANE GLYCOPROTEINS; MONOCYTES; NF-KAPPA B; NITROBENZENES; RECOMBINANT FUSION PROTEINS; SULFONAMIDES; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 81755172883     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1018994108     Document Type: Article

References (31)

1. Zhou LJ, Schwarting R, Smith HM, Tedder TF (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149(2):735-742.
2. Zhou L-J, Tedder TF (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154(8):3821-3835.
3. Breloer M, Fleischer B (2008) CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol 29(4):186-194.
4. Hock BD, Kato M, McKenzie JL, Hart DN (2001) A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int Immunol 13(7):959-967. (Pubitemid 32685208)
5. Lechmann M, et al. (2001) The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 194(12):1813-1821. (Pubitemid 34028660)
6. Scholler N, Hayden-Ledbetter M, Hellström KE, Hellstrom I, Ledbetter JA (2001) CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells. J Immunol 166(6):3865-3872. (Pubitemid 32224912)
7. Aerts-Toegaert C, et al. (2007) CD83 expression on dendritic cells and T cells: Correlation with effective immune responses. Eur J Immunol 37(3):686-695. (Pubitemid 46916935)
8. Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A (2007) CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178(9):5454-5464. (Pubitemid 46674339)
9. Fujimoto Y, et al. (2002) CD83 expression influences CD4+ T cell development in the thymus. Cell 108(6):755-767. (Pubitemid 34327528)
10. Kretschmer B, et al. (2008) CD83 on murine APC does not function as a costimulatory receptor for T cells. Immunol Lett 120(1-2):87-95.
11. Cramer SO, et al. (2000) Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int Immunol 12(9):1347-1351. (Pubitemid 30657779)
12. Zinser E, Lechmann M, Golka A, Lutz MB, Steinkasserer A (2004) Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J Exp Med 200(3):345-351. (Pubitemid 39031253)
13. Sénéchal B, Boruchov AM, Reagan JL, Hart DN, Young JW (2004) Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103(11):4207-4215. (Pubitemid 38685365)
14. Couper KN, Blount DG, Riley EM (2008) IL-10: The master regulator of immunity to infection. J Immunol 180(9):5771-5777.
15. Goodwin JS, Bankhurst AD, Messner RP (1977) Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 146(6):1719-1734. (Pubitemid 8245453)
16. Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2(1):46-53. (Pubitemid 37328775)
17. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG (2001) Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res 61(6):2720-2726. (Pubitemid 32685860)
18. Maihöfner C, et al.; Colorectal Cancer Group (2003) Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 24(4):665-671. (Pubitemid 36592401)
19. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182.
20. 2-dependent mechanism. Int Immunol 20(2):235-245.
21. Yamamoto K, Arakawa T, Ueda N, Yamamoto S (1995) Transcriptional roles of nuclear factor κ B and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270:31315-31320.
22. 2 production. J Immunol 182(1):554-562.
23. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8(1):34-47.
24. van Mirre E, Teeling JL, van der Meer JW, Bleeker WK, Hack CE (2004) Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb. J Immunol 173(1):332-339. (Pubitemid 38797358)
25. Passwell J, Levanon M, Davidsohn J, Ramot B (1983) Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity. Clin Exp Immunol 51(1):61-68. (Pubitemid 13168161)
26. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 177(1):246-254.
27. Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282:11613-11617. (Pubitemid 47100657)
28. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP (2002) Prostaglandins as modulators of immunity. Trends Immunol 23(3):144-150. (Pubitemid 34178297)
29. Xiang Y, et al. (2007) JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA 104:19226-19231.
30. Sun YM, et al. (2008) Broad profiling of DNA-binding transcription factor activities improves regulatory network construction in adult mouse tissues. J Proteome Res 7:4455-4464.
31. Renard P, et al. (2001) Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 29(4):E21.